| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Inhibikase Therapeutics Inc (NASDAQ: IKT)
IKT Technical Analysis
5
| As on 9th Jun 2023 IKT STOCK Price closed @ 0.68 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.04 & Strong Sell for SHORT-TERM with Stoploss of 1.37 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IKTSTOCK Price
| Open | 0.69 | Change | Price | % |
| High | 0.70 | 1 Day | -0.01 | -1.45 |
| Low | 0.68 | 1 Week | 0.06 | 9.68 |
| Close | 0.68 | 1 Month | 0.08 | 13.33 |
| Volume | 22507 | 1 Year | -0.95 | -58.28 |
| 52 Week High 1.77 | 52 Week Low 0.46 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| IKT Daily Charts |
IKT Intraday Charts |
Whats New @ Bazaartrend |
IKT Free Analysis |
|
|
IKT Important Levels Intraday
| RESISTANCE | 0.72 |
| RESISTANCE | 0.71 |
| RESISTANCE | 0.70 |
| RESISTANCE | 0.69 |
| SUPPORT | 0.67 |
| SUPPORT | 0.66 |
| SUPPORT | 0.65 |
| SUPPORT | 0.64 |
IKT Forecast May 2024
| 4th UP Forecast | 1.93 |
| 3rd UP Forecast | 1.53 |
| 2nd UP Forecast | 1.28 |
| 1st UP Forecast | 1.03 |
| 1st DOWN Forecast | 0.33 |
| 2nd DOWN Forecast | 0.08 |
| 3rd DOWN Forecast | -0.17 |
| 4th DOWN Forecast | -0.57 |
IKT Weekly Forecast
| 4th UP Forecast | 1.24 |
| 3rd UP Forecast | 1.06 |
| 2nd UP Forecast | 0.95 |
| 1st UP Forecast | 0.84 |
| 1st DOWN Forecast | 0.52 |
| 2nd DOWN Forecast | 0.41 |
| 3rd DOWN Forecast | 0.30 |
| 4th DOWN Forecast | 0.12 |
IKT Forecast2024
| 4th UP Forecast | 3.3 |
| 3rd UP Forecast | 2.46 |
| 2nd UP Forecast | 1.94 |
| 1st UP Forecast | 1.42 |
| 1st DOWN Forecast | -0.06 |
| 2nd DOWN Forecast | -0.58 |
| 3rd DOWN Forecast | -1.1 |
| 4th DOWN Forecast | -1.94 |
Inhibikase Therapeutics Inc ( NASDAQ USA Symbol : IKT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IKT Business Profile
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointestinal complications that arise as early symptoms of PD, such as swallowing, dysphagia and neurogenic constipation; and IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects. It also develops IkT-01427, a product candidate that blocks the causative virus of progressive multifocal leukoencephalopathy from replicating in the body. The company has collaborations with The Johns Hopkins University; Louisiana State University School of Medicine, Shreveport; and Memorial Sloan-Kettering Cancer Center. The company was founded in 2008 and is headquartered in Atlanta, Georgia. Address: 3350 Riverwood Parkway SE, Atlanta, GA, United States, 30339
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service